Repositório Digital

A- A A+

Novel therapeutic mechanisms determine the effectiveness of lipid-core nanocapsules on melanoma models

.

Novel therapeutic mechanisms determine the effectiveness of lipid-core nanocapsules on melanoma models

Mostrar registro completo

Estatísticas

Título Novel therapeutic mechanisms determine the effectiveness of lipid-core nanocapsules on melanoma models
Autor Drewes, Carine Cristiane
Fiel, Luana Almeida
Bexiga, Celina Goulart
Asbahr, Ana Carolina Cavazzin
Uchiyama, Mayara Klimuk
Cogliati, Bruno
Araki, Koiti
Guterres, Silvia Stanisçuaski
Pohlmann, Adriana Raffin
Farsky, Sandra Helena Poliselli
Abstract Melanoma is a severe metastatic skin cancer with poor prognosis and no effective treatment. Therefore, novel therapeutic approaches using nanotechnology have been proposed to improve therapeutic effectiveness. Lipid-core nanocapsules (LNCs), prepared with poly(ε-caprolactone), capric/caprylic triglyceride, and sorbitan monostearate and stabilized by polysorbate 80, are efficient as drug delivery systems. Here, we investigated the effects of acetyleugenol-loaded LNC (AcE-LNC) on human SK-Mel-28 melanoma cells and its therapeutic efficacies on melanoma induced by B16F10 in C57B6 mice. LNC and AcE-LNC had z-average diameters and zeta potential close to 210 nm and -10.0 mV, respectively. CytoViva® microscopy images showed that LNC and AcE-LNC penetrated into SK-Mel-28 cells, and remained in the cytoplasm. AcE-LNC in vitro treatment (18–90×109 particles/mL; 1 hour) induced late apoptosis and necrosis; LNC and AcE-LNC (3–18×109 particles/mL; 48 hours) treatments reduced cell proliferation and delayed the cell cycle. Elevated levels of nitric oxide were found in supernatant of LNC and AcE-LNC, which were not dependent on nitric oxide synthase expressions. Daily intraperitoneal or oral treatment (days 3–10 after tumor injection) with LNC or AcE-LNC (1×1012 particles/day), but not with AcE (50 mg/kg/day, same dose as AcE-LNC), reduced the volume of the tumor; nevertheless, intraperitoneal treatment caused toxicity. Oral LNC treatment was more efficient than AcE-LNC treatment. Moreover, oral treatment with nonencapsulated capric/caprylic triglyceride did not inhibit tumor development, implying that nanocapsule supramolecular structure is important to the therapeutic effects. Together, data herein presented highlight the relevance of the supramolecular structure of LNCs to toxicity on SK-Mel-28 cells and to the therapeutic efficacy on melanoma development in mice, conferring novel therapeutic mechanisms to LNC further than a drug delivery system.
Contido em International Journal of Nanomedicine. Manchester. Vol. 11 (Mar. 2016), p. 1261-1279
Assunto Nanocapsulas poliméricas
Nanotecnologia
Nanotoxicologia
Origem Estrangeiro
Tipo Artigo de periódico
URI http://hdl.handle.net/10183/141350
Arquivos Descrição Formato
000991147.pdf (4.369Mb) Texto completo Adobe PDF Visualizar/abrir

Este item está licenciado na Creative Commons License

Este item aparece na(s) seguinte(s) coleção(ões)


Mostrar registro completo

Percorrer



  • O autor é titular dos direitos autorais dos documentos disponíveis neste repositório e é vedada, nos termos da lei, a comercialização de qualquer espécie sem sua autorização prévia.
    Projeto gráfico elaborado pelo Caixola - Clube de Criação Fabico/UFRGS Powered by DSpace software, Version 1.8.1.